These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7426837

  • 1. Direct vasodilatation by labetalol in anaesthetized dogs.
    Dage RC, Hsieh CP.
    Br J Pharmacol; 1980 Oct; 70(2):287-93. PubMed ID: 7426837
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The use of labetalol in producing deliberate hypotension and its effects on intracranial pressure in dogs.
    Van Aken H, Puchstein C, Hidding J.
    Acta Anaesthesiol Belg; 1982 Oct; 33(1):5-12. PubMed ID: 7090725
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacology of labetalol in experimental animals.
    Baum T, Sybertz EJ.
    Am J Med; 1983 Oct 17; 75(4A):15-23. PubMed ID: 6314811
    [Abstract] [Full Text] [Related]

  • 11. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
    Sybertz EJ, Sabin CS, Pula KK, Vliet GV, Glennon J, Gold EH, Baum T.
    J Pharmacol Exp Ther; 1981 Aug 17; 218(2):435-43. PubMed ID: 6114171
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hypotensive and vascular effects of labetalol in the normotensive rat and dog.
    Hashimoto K, Hashimoto T, Iizuka H, Tsukada T, Matsuda H, Imai S.
    Jpn Heart J; 1978 Sep 17; 19(5):762-74. PubMed ID: 32409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cardiovascular properties of medroxalol, a new antihypertensive drug.
    Dage RC, Cheng HC, Woodward JK.
    J Cardiovasc Pharmacol; 1981 Sep 17; 3(2):299-315. PubMed ID: 6166802
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamic effects of labetalol in the dog. Comparative study in the anesthetized open-chest dog and in the conscious dog.
    Saito D, Abe Y, Tani H, Kusachi S, Takeda K, Hyodo T, Haraoka S, Nagashima H.
    Arzneimittelforschung; 1986 Sep 17; 36(1):88-91. PubMed ID: 2869764
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cardiovascular effects of labetalol during halothane anaesthesia.
    Scott DB, Buckley FP, Drummond GB, Littlewoods DG, Macrae WR.
    Br J Clin Pharmacol; 1976 Aug 17; 3(4 Suppl 3):817-21. PubMed ID: 990159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.